SCROLL DOWN↓
RESEARCH

What the research says.

Nine findings from the clinical literature, in three groups: the problem, what helps, and what to track.

1THE PROBLEM

Inhalers are often used incorrectly, and it affects asthma control.

31%
of patients used their inhaler correctly
31 in every 100 used it correctly69 did not
Correct31%
Acceptable41%
Poor31%
Pooled from 144 studies over 40 years, with no improvement over that time. A separate review of 28 studies found children's technique to be generally poor.
Sanchis et al., Chest 2016 · Gillette et al., Acad Pediatr 2016
46%
of patients did not hold their breath after inhaling
No breath-hold46%
Poor timing45%
Breathing in too fast44%
The three most common errors with metered-dose inhalers each affected almost half of patients.
Sanchis et al., Chest 2016
1.55×
the odds of uncontrolled asthma when the inhaler is pressed before breathing in
Pressed too early1.55×
Correct timing1.00×
From the CRITIKAL study of 3,660 patients in eight countries, which linked specific inhaler errors to worse asthma control.
Price et al., J Allergy Clin Immunol Pract 2017
2WHAT HELPS

Teaching works when it is repeated and observed.

37 of 39
training programmes significantly improved inhaler technique
The benefit faded as time passed since the training, so the authors recommend repeating it at regular intervals.
Klijn et al., NPJ Prim Care Respir Med 2017
37 improved technique2 did not
57%
of the dose reached the lungs when children aged 8 to 10 held their breath
With normal breathing through the same spacer it was about 48%. One deep breath and a hold of 5 to 10 seconds delivered more medicine at every age studied.
Roller et al., Eur Respir J 2007
Deep breath and hold57%
Normal breathing48%
18 of 18
children still taking part had effective technique by week 5
22 children with difficult-to-treat asthma filmed their inhaler use at home. Clinicians reviewed each video and gave feedback.
Shields et al., PLoS One 2018
18 effective technique at week 54 stopped taking part
3WHAT TO TRACK

Control depends on symptoms over time, the air, and staying engaged.

4 questions about the last 4 weeks define asthma symptom control.
1Daytime symptoms more than twice a week?
2Any night waking due to asthma?
3Reliever needed more than twice a week?
4Any activity limitation due to asthma?
GINA, the international asthma strategy, grades control as well, partly or not controlled from four yes-or-no answers.
Global Initiative for Asthma, 2024
So, our
approach.

Nimbi checks the technique itself, every day.

The camera coach talks the child through each step and confirms it happened: the devices, the shake, the lip seal, the puff and a ten-second breath-hold. Practice repeats daily, at home, with the child's own inhaler.

RESPONDS TO
31% used it correctly37 of 39 programmes57% with a breath-hold18 of 18 observed at home
0
HOLD · 10 S
–Inhaler and spacer found
–Shake counted
–Lips sealed on the mouthpiece
–Puff heard
–Breath held for 10 seconds
REFERENCES
Sanchis J, Gich I, Pedersen S. Chest. 2016;150(2):394–406.
Gillette C, Rockich-Winston N, Kuhn JA, et al. Acad Pediatr. 2016;16(7):605–615.
Price DB, Román-Rodríguez M, McQueen RB, et al. J Allergy Clin Immunol Pract. 2017;5(4):1071–1081.
Klijn SL, Hiligsmann M, Evers SMAA, et al. NPJ Prim Care Respir Med. 2017;27:24.
Laube BL, Janssens HM, de Jongh FHC, et al. Eur Respir J. 2011;37(6):1308–1331.
Roller CM, Zhang G, Troedson RG, et al. Eur Respir J. 2007;29(2):299–306.
Shields MD, ALQahtani F, Rivey MP, McElnay JC. PLoS One. 2018;13(2):e0190031.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2024.
Orellano P, Quaranta N, Reynoso J, et al. PLoS One. 2017;12(3):e0174050.
Aguilera R, Corringham T, Gershunov A, et al. Pediatrics. 2021;147(4):e2020027128.
Charlier N, Zupancic N, Fieuws S, et al. J Am Med Inform Assoc. 2016;23(1):230–239.
Paper pages shown at the top: Orellano et al. 2017 and Shields et al. 2018 (PLOS ONE), and Klijn et al. 2017 (npj Primary Care Respiratory Medicine), reproduced under the Creative Commons Attribution licence.
STATUS AND LIMITATIONS

What is shown so far, and what is not.

The evidence above supports the design of Nimbi. It does not show that Nimbi itself works. Nimbi is a working prototype that has not yet been through a clinical study, and the studies below are the next stage of the project.

DONE

What has been done

A working prototype
Nimbi Lost Sky runs on an iPhone: the game, the daily check-in, the record, and the camera Coach, which checks eight steps of inhaler technique on the phone.
Clinician feedback
Clinicians have reviewed the prototype informally and given feedback on its design.
Early use
A small convenience sample has used the prototype. This was informal testing, not a study, and it is not presented as evidence.
A measured detector
On held-out images the object detector reaches a mean average precision of 0.951 at an IoU of 0.5. This is a bench measurement of one component.
LIMITATIONS

What is not yet known

No clinical outcomes yet
Whether daily checking improves technique, symptom control or the rate of attacks has not been measured.
The Coach is not yet validated against a clinician
Its step-by-step result has not been compared with a trained observer scoring the same practice.
Narrow testing
The detector was trained and tested on one inhaler and one spacer, on iPhones with Face ID.
Self-reported symptoms
Check-in answers follow the GINA questions but come from the child. They have not been compared with a clinician's assessment or a validated questionnaire such as the Childhood Asthma Control Test.
Not a medical device
Nimbi gives no dosing advice, does not replace a clinician, and has had no regulatory review.
NEXT

The studies planned

The founder is seeking a principal investigator to supervise this work. The stages run in order; each depends on the one before it.

1
Supervision and ethics
Work under a principal investigator in paediatric respiratory medicine, write the study protocol, and obtain research ethics approval.
2
Validation study
Compare the Coach with trained clinicians scoring the same recorded practices in children aged 8 to 10. Outcome: agreement on each step (sensitivity, specificity, Cohen's κ).
3
Feasibility pilot
Families use Nimbi at home over several weeks. Outcomes: how often it is used, whether children and parents accept it, and change in technique.
4
Controlled trial
Nimbi against usual inhaler education. Outcomes: technique, symptom control, reliever use and unscheduled visits.
5
Publication
A methods paper on the Coach with the validation results, followed by the pilot.